Heaven forfend the U.S. be left behind in a post about religion and politics: Obama's move to lift the ban of federal
funding of embryonic stem cell research didn't sit well with several U.S. states, which have now passed or are considering legislation to outlaw some forms of the work.
WASHINGTON — Seven years after President Bush blocked most federal
funding of embryonic stem cell research, the controversial science is likely to get a fresh look from the next occupant of the White House, no matter who it is.
In September 2010, The New York Times reported that the U.S. Court of Appeals ruled that federal
funding of embryonic stem cell research could continue under the new rules while the court considers Judge Lamberth's ruling [source: New York Times].
Obama's administration allowed federal
funding of embryonic stem cell research if the following conditions applied:
The Coalition for the Advancement of Medical Research argues that seven in ten Americans want to eliminate restrictions on public
funding of embryonic stem cell research, while the Conference of Catholic Bishops points to a poll showing six in ten oppose such funding altogether.
\ n \ nWhile historically there had been a ban on taxpayer
funding of embryonic stem cell research, there has never been a ban on private funding in this country and many European countries have allowed this type of research for years, but so far none of this research has yielded a single therapeutic use.
Teitelbaum says the new Democrat majority in the U.S. House could bolster efforts to expand federal
funding of embryonic stem cell research beyond the limits that President George W. Bush laid down in 2001.
Shortly after his inauguration, Bush ordered a review of the current National Institutes of Health (NIH) policy, which allows
the funding of embryonic stem cell studies as long as researchers receive the cells from privately funded researchers who have derived them in accord with a set of ethical guidelines (ScienceNOW, 23 August 2000).
We oppose federal
funding of embryonic stem cell research.»
Not exact matches
Proponents
of the anything - goes position assert that the potential scientific and medical benefits
of embryonic stem -
cell research override all other considerations» and therefore restrictions on the
funding and scope
of this research are unwarranted.
Not surprisingly, President Obama received high marks from the journal, largely because his response to the question
of whether he would lift Bush's ban on the federal
funding of new
embryonic stem -
cell lines is in line with the view
of most in the scientific community.
The National Institutes
of Health (NIH) has allowed a contract for the dissemination
of embryonic stem cell lines approved for US government
funding to lapse, shuttering a key
stem cell bank, and doubling the price researchers pay for samples
of some human
embryonic stem cell (hESC) line... from $ 500 per vial
of frozen
cells to $ 1,000.
In August
of last year, President Bush approved the use
of federal
funds to support research on a limited number
of existing human
embryonic stem cell lines.
Proponents
of embryonic stem cell research argue that restricting federal
funding to a limited....
Less incredible, and perhaps only to be expected, is the news that Peter Jackson and Fran Walsh, the dynamic duo who brought The Lord
of the Rings to the silver screen, have donated $ 310,000 from the movie's profits to
fund human
embryonic stem -
cell research.
He decreed that the case brought by researchers Drs James Sherley and Theresa Deisher, along with a number
of Christian groups including the Christian Medical Association, should be heard; and ordered an injunction temporarily blocking federal
funding allocated for human -
embryonic -
stem -
cell research.
But on the same day, he also revoked the very kind
of policy that promoted the «purple» governance he claimed to want, e.g., Bush's directive that
funding priority be given to
funding non
embryonic — and hence, societally uniting sources
of pluripotent
stem cells — even though they had already been discovered in the induced pluripotent
stem cell breakthrough.
He ruled that work on existing
embryonic stem cell lines derived outside federally
funded labs did not violate a ban on the destruction
of embryos.
The year's most prominent science issue, federal support
of embryonic stem cell research, is so controversial that the sons
of Ronald Reagan gave dueling speeches at the opposing party conventions; Michael Reagan backs President George W. Bush's policies, including the ban on
funding for research on new
stem cell lines, while Ron supports Senator John Kerry's promise to lift restrictions.
In granting an injunction to two scientists who oppose widening US government
funding for research on human
embryonic stem cells (hESCs), Judge Royce Lamberth wrote
of «simply preserving the status quo».
Congressional supporters
of stem cell research have re-introduced legislation to codify President Barack Obama's 2009 executive order lifting restrictions on the number
of human
embryonic stem cell lines available to federally
funded researchers.
They then argue that «By creating a financial incentive for
embryonic stem cell research — an incentive that by NIH's own admission involves investments
of «hundreds
of millions
of dollars» — and by specifying the precise means by which embryos must be destroyed in order to qualify for federal
funding, the NIH necessarily and knowingly subjects embryos to a substantial risk
of injury or death.»
Collins and others argue not just for a permanent removal
of the injunction to resume research with confidence, but also for an extension
of the number
of embryonic stem cell lines available to federally
funded researchers.
He has also been an inveterate foe
of abortion, a position that informed his repeated votes against expanding the number
of human
embryonic stem cell lines available to NIH -
funded researchers during the George W. Bush administration.
Under the Obama administration, the number
of embryonic stem cell lines available for federally
funded research had more than tripled, but no money was going toward the creation
of any
cell lines (a process that destroys the embryo).
Now, many research advocates are wondering how Price's mix
of views might play out in the new administration's approach to a wide range
of issues, including
funding, research involving human
embryonic stem cells and fetal tissue, and the appointment
of a new NIH director.
But just how close adult and reprogrammed
stem cells can come to matching the capabilities
of embryonic stem cells has become a contentious question in the debate over whether the federal government should continue
funding research on
embryonic lines.
Lamberth interprets that to include
funding of research on human
embryonic stem cells more broadly, even though the Department
of Health and Human Services and several presidential Administrations have not agreed.
In late 2004, California voters approved Proposition 71, allocating $ 3 billion over 10 years, making California the largest single
funder of embryonic and pluripotent
stem cell research in the world and consequently one
of the strongest job markets for regenerative research.
This set the stage for a relatively restrictive environment for
embryonic (although not adult)
stem cell research in the United States relative to some other countries — the National Institutes
of Health currently
funds between about $ 600 miilion to $ 700 million a year in
stem cell research.
Research on
embryonic stem cells funded by the U.S. government must stop immediately for a court - ordered review, Judge Royce Lamberth
of the U.S. District Court for the District
of Columbia ruled today.
The final guidelines on research with human
embryonic stem cells issued on Monday by the National Institutes
of Health set out criteria for determining which ES
cell lines can be used in federally
funded experiments and give NIH discretion to approve old lines that don't meet stringent modern ethical requirements.
Lamberth granted a preliminary injunction on this research after hearing a petition from a group
of advocates who argued that, contrary to the U.S. government's view, research on
embryonic stem cells does in fact destroy embryos — action that is prohibited by legislation known as the «Dickey - Wicker Amendment» to the bill that
funds the Department
of Health and Human Services.
This barrier has been highly visible in the field
of human
embryonic stem cell research, where researchers in the United States must adhere to legislation and
funding limitations that researchers in European countries have not faced.
The National Institutes
of Health (NIH) is scrambling to push out research grants for work on human
embryonic stem cells (hESCs) and has given a cautious all - clear to in - house
stem cell researchers after an appeals court yesterday temporarily lifted a ban on federal
funding for hESC research.
In the latest twist in an increasingly complex legal struggle, the Department
of Justice (DOJ) has appealed a judge's refusal on Tuesday to remove the ban on
funding for human
embryonic stem cell (hESC) research.
The National Institutes
of Health (NIH) pleased
stem cell watchers today by announcing the names
of 10 companies and research groups that have human
embryonic stem cells federally
funded researchers can use.
«We are in an era where the primary issues are not federal
funding for human
embryonic stem cell research,» wrote CAMR President Amy Comstock Rick, who is also CEO
of the Parkinson's Action Network, in an e-mail to the more than 100 patient advocacy, scientific, and other groups that belong to CAMR.
In September the British Parliament
funded an
embryonic -
stem -
cell bank that may eventually store thousands
of cell lines, which will help make Britain a leader in
embryonic -
stem -
cell research.
But last April he also voted for the HOPEAct, a Bush - supported «compromise» bill that would open up federal
funding for research that does not involve the creation, destruction, or injury
of embryos; seeing as there are not yet any
embryonic stem cells lines that meet this condition (ACT hasn't yet proven that their technique poses no «risk
of injury»), the HOPE
funding would only be available for non-
embryonic stemcells.
Both Obama and Clinton voted against the Hope Act and many
stem cell research supporters have criticized the bill, saying it's a distraction and diversion
of funds away from the greater promise
of embryonic cells.
The 2012 platform also repeats previous calls for expanding federal
funding «for the
stem -
cell research that now offers the greatest hope for many afflictions — with adult
stem cells, umbilical cord blood, and
cells reprogrammed into pluripotent
stem cells — without the destruction
of embryonic human life.»
If dealing with the public relations nightmare over its on - off - on
funding of Planned Parenthood wasn't enough, the Susan G. Komen for the Cure cancer charity last week also got entangled, somewhat bizarrely, in the debate over human
embryonic stem (ES)
cell research.
A U.S. appeals court today upheld the legality
of federally
funded research on human
embryonic stem cells (hESCs)-- the latest in a string
of wins for the National Institutes
of Health (NIH) in a 3 - year legal battle with groups that for moral reasons want to block the use
of these
cells.
UC announced yesterday that it is the first research institution to seek to «intervene,» or become a party in the case, in which the government is appealing a lower court's ruling that National Institutes
of Health (NIH)
funding to study human
embryonic stem cells (hESCs) violates federal law.
Meanwhile, Senators Arlen Specter (R - Pennsylvania) and Tom Harkin (D - Iowa) introduced a bill on 5 April that would authorize NIH to
fund derivation
of and research on human
embryonic stem cells.
A noted U.S. fertility researcher is relocating to England in a move that some researchers say underscores the uncertainty created by the current debate over government
funding of research involving
embryonic stem cells (Science, 13 July, p. 186).
Attempting to find middle ground in the contentious debate over human
embryonic stem cells, President George W. Bush announced 9 August that the National Institutes
of Health (NIH) will be allowed to
fund work with
embryonic stem (ES)
cell lines — but only those lines that have already been derived.
A bill that would allow federal
funding for derivation
of new lines
of human
embryonic stem (ES)
cells passed the U.S. House
of Representatives yesterday 238 to 194 after more than four hours
of debate.
First, promising to restore the integrity
of science while seeking vast medical benefits for many, President Obama repealed the restrictions set by President Bush on the use
of federal
funds for
embryonic stem cell research.